Healthcare provider profile · identity verified

Keshia Guerrier

Physician Assistant · BRONX, NY · NPI 1346780830

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	247	65
Atorvastatin Calcium	Atorvastatin Calcium	234	53
Gabapentin	Gabapentin	163	46
Levothyroxine Sodium	Levothyroxine Sodium	161	35
Metoprolol Succinate	Metoprolol Succinate	121	36
Simvastatin	Simvastatin	107	27
Metformin Hcl	Metformin Hcl	100	33
Pantoprazole Sodium	Pantoprazole Sodium	93	24
Losartan Potassium	Losartan Potassium	86	31
Eliquis	Apixaban	83	23
Lisinopril	Lisinopril	79	19
Januvia	Sitagliptin Phosphate	78	16
Famotidine	Famotidine	72	20
Tamsulosin Hcl	Tamsulosin Hcl	70	17
Albuterol Sulfate Hfa	Albuterol Sulfate	65	28
Omeprazole	Omeprazole	64	17
Rosuvastatin Calcium	Rosuvastatin Calcium	61	17
Hydrochlorothiazide	Hydrochlorothiazide	56	13
Hydrocortisone	Hydrocortisone	56	16
Montelukast Sodium	Montelukast Sodium	56	11
Mirtazapine	Mirtazapine	48	12
Diclofenac Sodium	Diclofenac Sodium	41	14
Metoprolol Tartrate	Metoprolol Tartrate	39	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	39	16
Sertraline Hcl	Sertraline Hcl	35	11
Nystatin	Nystatin	34	suppressed
Furosemide	Furosemide	33	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	14
Jardiance	Empagliflozin	30	suppressed
Carvedilol	Carvedilol	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Ammonium Lactate	Ammonium Lactate	27	12
Fenofibrate	Fenofibrate	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	12
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Dutasteride	Dutasteride	24	suppressed
Latanoprost	Latanoprost	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Trazodone Hcl	Trazodone Hcl	24	suppressed
Prednisone	Prednisone	23	12
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	13
Olanzapine	Olanzapine	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	11
Allopurinol	Allopurinol	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Azithromycin	Azithromycin	17	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Potassium Chloride	Potassium Chloride	15	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Atenolol	Atenolol	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Baclofen	Baclofen	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Torsemide	Torsemide	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Ssd	Silver Sulfadiazine	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error